Table 3 –
Percentage difference of the geometry metrics for all the pathological study scenarios with reference to the healthy TV.
| APCV-1 | APCV-2 | APCV-3 | ASCV-1 | ASCV-2 | ASCV-3 | PSCV-1 | PSCV-2 | PSCV-3 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Tenting Area | H | 73.4 mm2 | 86.7 mm2 | 94.9 mm2 | 19.9 mm2 | 6.0 mm2 | 12.5 mm2 | 8.4 mm2 | 7.1 mm2 | 18.1 mm2 |
| UAD | +140.7% | +171.9% | +174.4% | +5.8% | +403.1% | +341.9% | +584.9% | +696.0% | +388.9% | |
| NAD | +71.2% | +142.0% | +185.5% | +253.8% | +1023.5% | +544.6% | +1263.7% | +1611.2% | +835.8% | |
| PMD | +242.0% | +257.6% | +283.4% | +389.8% | +1881.9% | +1102.4% | +1778.1% | +2419.2% | +1129.0% | |
| PH | −18.7% | −17.9% | −17.8% | −53.0% | −49.8% | −50.4% | −36.7% | −49.8% | −41.5% | |
| Tenting Height | H | 6.2 mm | 7.9 mm | 9.5 mm | 12.8 mm | 2.4 mm | 3.1 mm | 3.2 mm | 2.9 mm | 4.4 mm |
| UAD | +55.3% | +78.7% | +77.8% | −56.7% | +150.3% | +134.2% | +172.4% | +174.6% | +131.5% | |
| NAD | +6.7% | +54.9% | +58.1% | −30.2% | +233.6% | +177.8% | +304.3% | +294.7% | +230.6% | |
| PMD | +279.2% | +209.7% | +162.6% | −2.6% | +454.6% | +428.7% | +494.9% | +665.2% | +449.6% | |
| PH | −11.1% | −11.4% | −15.4% | −70.2% | −22.9% | −26.3% | −12.2% | −25.4% | −22.3% | |
| Coaptation Height | H | 30.1 mm | 6.4 mm | 7.0 mm | 5.6 mm | 11.7 mm | 11.8 mm | 14.3 mm | 13.4 mm | 12.2 mm |
| UAD | −32.5% | −93.6% | −58.1% | +14.2% | −49.0% | −54.6% | −60.7% | −38.7% | −50.2% | |
| NAD | −36.9% | +266.6% | −57.5% | +30.9% | −57.7% | −53.7% | −58.0% | −57.2% | −67.0% | |
| PMD | −88.0% | −18.5% | −10.6% | +93.8% | −20.5% | −41.6% | −46.4% | −51.9% | −28.8% | |
| PH | +1.8% | +13.8% | +13.0% | +95.3% | +1.1% | +0.6% | −2.6% | +2.7% | +5.0% |
Acronyms: APCV: anterior-posterior cut view, ASCV: anterior-septal cut view, PSCV: posterior-septal cut view, H: healthy, UAD: uniform annulus dilation, NAD: non-uniform annulus dilation, PMD: papillary muscle displacement, and PH: pulmonary hypertension